MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, QNRX has $20,390,569 in assets. $7,270,663 in debts. $3,818,096 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
360.69%
Quick Ratio
360.69%
Cash Ratio
68.83%
Debt to Asset Ratio
35.66%
Unit: Dollar
Assets Breakdown
    • Investments
    • Cash and cash equivalents
    • Intangible assets, net
Liabilities Breakdown
    • Additional paid in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
3,818,096
Investments
14,927,165
Prepaid expenses and other current assets
1,261,974
Total current assets
20,007,235
Intangible assets, net
383,334
Total assets
20,390,569
Accounts payable
1,262,222
Accrued expenses
2,538,457
Accrued interest and financing expense
1,146,251
Due to officers - short term
600,000
Total current liabilities
5,546,930
Due to officers - long term
1,723,733
Total liabilities
7,270,663
Ordinary shares, no par value per share, 5,000,000,000 and 100,000,000 ordinary shares authorized at december 31, 2025 and december 31, 2024, respectively - 52,441,360 (1,498,325 ads's) ordinary shares issued and outstanding at december 31, 2025 and 8,948,164 (255,661 ads's) ordinary shares issued and outstanding at december 31, 2024
0
Accumulated other comprehensive loss
-613
Additional paid in capital
84,090,966
Accumulated deficit
-70,970,447
Total shareholders' equity
13,119,906
Total liabilities and shareholders' equity
20,390,569
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$14,927,165 Cash and cashequivalents$3,818,096 Prepaid expenses andother current assets$1,261,974 Total current assets$20,007,235 Intangible assets, net$383,334 Total assets$20,390,569 Total liabilities andshareholders' equity$20,390,569 Total shareholders'equity$13,119,906 Total liabilities$7,270,663 Accumulated deficit-$70,970,447 Accumulated othercomprehensive loss-$613 Additional paid in capital$84,090,966 Total currentliabilities$5,546,930 Due to officers -long term$1,723,733 Accrued expenses$2,538,457 Accounts payable$1,262,222 Accrued interest andfinancing expense$1,146,251 Due to officers -short term$600,000

Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals, Ltd. (QNRX)